These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30178843)

  • 1. PCAT6 participates in the development of gastric cancer through endogenously competition with microRNA-30.
    Xu Y; Sun JY; Jin YF; Yu H
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5206-5213. PubMed ID: 30178843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of long non-coding RNA PCAT6 restrains gastric cancer cell proliferation and epithelial-mesenchymal transition by targeting microRNA-15a.
    Dong D; Lun Y; Sun B; Sun H; Wang Q; Yuan G; Quan J
    Gen Physiol Biophys; 2020 Jan; 39(1):1-12. PubMed ID: 32039820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc Finger Protein 521, Negatively Regulated by MicroRNA-204-5p, Promotes Proliferation, Motility and Invasion of Gastric Cancer Cells.
    Huan C; Xiaoxu C; Xifang R
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819874783. PubMed ID: 31526099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN.
    Kong FR; Lv YH; Yao HM; Zhang HY; Zhou Y; Liu SE
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8230-8238. PubMed ID: 31646553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
    Dong JS; Wu B; Zha ZL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
    Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
    Yan K; Tian J; Shi W; Xia H; Zhu Y
    Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NR027113 promotes malignant progression of gastric carcinoma via EMT signaling pathway.
    Chen QF; Hu CF; Sun K; Lang YP
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4746-4755. PubMed ID: 31210301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1].
    Yang XY; Li N; Deng WY; Ma YJ; Han XL; Zhang ZY; Xie JL; Luo SX
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):193-199. PubMed ID: 30917455
    [No Abstract]   [Full Text] [Related]  

  • 13. The Long Noncoding RNA, Growth Arrest-Specific 5, Suppresses Gastric Cancer by Downregulating miR-21 Expression.
    Li W; Peng X; Wang Z; Zhang H; Huang H; Liu H; Cai L
    Pharmacology; 2020; 105(7-8):434-444. PubMed ID: 31910411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells.
    Wang C; Xie XX; Li WJ; Jiang DQ
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10410-10421. PubMed ID: 31841195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
    Yue QY; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
    Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
    EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CHRF promotes cell invasion and migration via EMT in gastric cancer.
    Gong J; Wang Y; Shu C
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1168-1176. PubMed ID: 32096147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis.
    Wang W; Li X; Guan C; Hu Z; Zhao Y; Li W; Jiang X
    Pathol Res Pract; 2020 Sep; 216(9):153074. PubMed ID: 32825947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.
    Chen XB; Li W; Chu AX
    J Cell Biochem; 2019 Jan; 120(1):470-480. PubMed ID: 30161272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.